Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

July 27, 2020 Issue

09829-cover-webopen.jpg

July 27, 2020 Cover

Volume 98, Issue 29

For the chemical companies who made our list, sales and profits took a hit in 2019, and 2020 will be worse

Cover image:Sales and profits across the chemical industry took a hit in 2019, and 2020 will be worse


Credit: Will Ludwig/C&EN/Shutterstock

Full Article
Volume 98 | Issue 29

All Issues

Quote of the Week

“COVID-19 is adhering to expectations on the sex differences. I realize that’s not a sexy quote for your readers. But it’s the truth.”

Andrew Noymer, associate professor of public health, University of California, Irvine

Finance

C&EN’s Global Top 50 for 2020

Sales and profits across the chemical industry took a hit in 2019, and 2020 will be worse

  • Mining medical isotopes from nuclear waste

    Actinium-225 is in demand. Nuclear innovation company TerraPower hopes nuclear waste can supply it

  • Periodic Graphics: Summer plant irritants

    Chemical educator and Compound Interest blogger Andy Brunning describes the chemistry behind the plants that make us itch and scratch

ADVERTISEMENT
image name
Vaccines

Four COVID-19 vaccine candidates induce immune responses in preliminary studies, but questions remain

CanSino, Moderna, Oxford, and Pfizer publish results from early clinical trials that show the vaccines may be safe and induce moderate antibody responses

ADVERTISEMENT
ADVERTISEMENT